Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Proteinase
71%
Protease
71%
Virus
47%
CXCR4
25%
Factor H
25%
In Vitro
20%
Reverse Transcriptase
20%
Tumor Cell
19%
Peptides
18%
Infection
16%
Infectious Disease
16%
Complement Dependent Cytotoxicity
16%
Recombinant Virus
15%
Phagocytosis
14%
Complement Activation
14%
Cross-Resistance
13%
Drug Resistance
12%
Heavy Chain
12%
Bacteriophage
12%
DNA Sequence
12%
Antibody Conjugate
12%
Cancer Cell
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Neutralizing Antibody
12%
Cell Fusion
12%
Trastuzumab
12%
Human Immunodeficiency Virus
11%
Complementarity Determining Region
11%
Susceptibility
10%
Wild Type
8%
Codon
8%
Neutralization
7%
Xenograft
7%
Natural Killer Cell
7%
C3b
6%
Viral Load
6%
Virus Spike
6%
Angiotensin
6%
Cladistics
5%
Macrophage
5%
Keyphrases
Protease Inhibitors
27%
Highly Active Antiretroviral Therapy (HAART)
25%
Genetic Resistance
25%
Recombinant Virus
20%
Protease
20%
Human Immunodeficiency Virus Type 1 (HIV-1)
18%
Herpes B Virus
15%
Reverse Transcriptase
13%
Virus
13%
HIV Protease Inhibitors
12%
Cross-resistance
12%
Line Probe Assay
12%
Human Immunodeficiency Virus Type 1 Protease
12%
HIV-1 Inhibition
12%
HER2 Breast Cancer
12%
Complement Activation
12%
Immunotherapeutics
12%
Immunotherapeutic Approaches
12%
Multimeric
12%
SARS-CoV-2 Neutralizing Antibodies
12%
Viral Neutralization Assay
12%
Angiotensin-converting Enzyme 2 Receptor
12%
Nanoluciferase
12%
High-throughput
12%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
12%
Fusion Assay
12%
Patient Samples
12%
Cell Fusion
12%
HIV Entry
12%
Memory Impairment
12%
Health Effects
12%
Post-COVID
12%
Clinical Progression
12%
Resistance Evaluation
12%
Luxembourg
12%
Ritonavir
11%
Indinavir
11%
Virus Protease
11%
LiPA
9%
Saquinavir
9%
Virological Outcome
8%
Nucleoside Reverse Transcriptase Inhibitors
8%
Coding Region
7%
Nelfinavir
7%
BT474
6%
Factor H Binding Protein
6%
Viral Entry
6%
Recombination
6%
Restriction Enzyme
6%
Split Luciferase
6%
Medicine and Dentistry
Highly Active Antiretroviral Therapy
37%
Human Immunodeficiency Virus 1
37%
Proteinase Inhibitor
36%
Resistance Mutation
28%
Drug Resistance
27%
Proteinase
27%
Virus
26%
Ritonavir
25%
HIV-1 Protease
22%
Indinavir
19%
Codon
18%
Saquinavir
16%
Cross Resistance
12%
DNA Sequence
12%
Protease
12%
Combination Therapy
12%
Human Immunodeficiency Virus
10%
Zidovudine
7%
Nelfinavir
6%
Nucleoside Analog
6%
Observational Study
5%
Prevalence
5%
Didanosine
5%
2',3' Dideoxynucleoside Derivative
5%